Big Gain For Entasis Therapeutics Holdings Inc.
Entasis Therapeutics Holdings Inc. (ETTX:NASDAQ) shot up at $1.8, representing a gain of 24.1%. On Mon, Jan 31, 2022, ETTX:NASDAQ touched a New 2-Week Low of $1.47. The stock got featured on our News Catalysts scanner on Mon, Jan 10, 2022 at 08:49 AM in the 'MISCELLANEOUS' category. From Tue, Jan 18, 2022, the stock recorded 11.11% Up Days and 10.00% Green Days
The stock spiked on Mon, Sep 20, 2021 at $3.88 with a volume of 1M+.
About Entasis Therapeutics Holdings Inc. (ETTX:NASDAQ)
Entasis Therapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company is engaged in the discovery, development, and commercialization of novel antibacterial products to treat serious infections caused by multi-drug resistant Gram-negative bacteria. It has the discovery, development, and commercialization of novel antibacterial products to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its products candidate includes etx2514sul, zoliflodacin, etx0282cpdp, and nbp program.
Top 10 Gainers:
- NOVONIX Limited (NVX:NASDAQ), 2966.67%
- MDJM Ltd. (MDJH:NASDAQ), 35.56%
- GWG Holdings, Inc. (GWGH:NASDAQ), 31.58%
- Great Panther Mining Limited (GPL:NYSEMKT), 31%
- Helbiz Inc. (HLBZ:NASDAQ), 24.84%
- Entasis Therapeutics Holdings Inc. (ETTX:NASDAQ), 24.14%
- Lixiang Education Holding Co. Ltd. (LXEH:NASDAQ), 20.69%
- Dragon Victory International Limited (LYL:NASDAQ), 18.1%
- UTime Limited (UTME:NASDAQ), 17.51%
- Allegheny Technologies Incorporated (ATI:NYSE), 17.07%